Skip to Main Content

Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers

By Cortechs.ai

2 mins

Study to determine the ability of clinically available volumetric MRI (vMRI) and CSF biomarkers, alone or in combination with a quantitative learning measure, to predict conversion to Alzheimer’s disease (AD) in patients with mild cognitive impairment (MCI). 2011 October 12.

Download

Share

Topic
Published research

Insights

5 mins

Oct 28 2024

How AI Will Transform Healthcare Students’ Experience

EDITORIAL: The potential applications of AI are vast, and how can early exposure to these technologies better prepare healthcare students?

Cortechs.ai news

4 mins

Oct 28 2024

The Benefits and Limitations of Neuroimaging AI Software in Traditional Diagnostic Workflow

Software like NeuroQuant offers powerful solutions that complement traditional diagnostic methods, enhancing both speed & accuracy

Cortechs.ai news

2 mins

Oct 14 2024

RANO 2D and 3D Measurements as a Companion Diagnostic Tool in NeuroQuant Brain Tumor

NeuroQuant’s Brain Tumor module automates RANO 2D and 3D measurements, providing clinicians with precise data to improve treatment planning and patient outcomes

Industry news

View our insights